RSS Feeds
Search

Companies

Companies

Displaying 11..14 of 14 - per page Previous page
Order by
Manchester Innovation
Commercial exploitation company of The University of Manchester More
American Biogenetic Sciences Inc
More
The Genetics Company, Inc.
More
Synaptica
Drug Discovery for neurodegenerative diseases More
Displaying 11..14 of 14 - per page Previous page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Diagnostics Partnering Terms and Agreements
Feb 2012 - 1350 pages - $2,695
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
The Market Outlook for Neurodegenerative Diseases
Sep 2010 - 137 pages - $3,835
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2010
Aug 2010 - 76 pages - $1,500
Emerging Technologies: Stem cells
Nov 2011 - 61 pages - $3,800
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us